NCT01842204

Brief Summary

A monocentric interventional randomized placebo controlled trial evaluating the efficacy of the post surgical and wound care recovery kit. It's a small device that consists of a thin metal ring that is placed on the skin surface, non-invasively. It's connected with a small battery. When the plastic tag is removed and the button is pushed the device is activated. Within the ring a Pulsed Electromagnetic Field is created. It influences the receptor-ligand binding at the cell surface and might improve wound healing by diminishing wound edema and inflammation. It possibly helps reducing the inflammatory reaction induced by surgery. Patients will be treated for uni or bilateral inguinal hernias and at the end of surgery, at the time of bandage, a kit will be applied at the level of the incision. One group will at random receive a working device, the other half will have a kit without active electromagnetic field. Postoperative analgesic consumption will be measured in a diary and pain and quality of life will be measured using Visual Analogue Scale and EuraHS-Quality Of Life questionnaires. The aim of this study is to evaluate whether the placement of the device reduces the acute postoperative pain and whether it reduces the incidence of chronic groin pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 29, 2013

Completed
2 days until next milestone

Study Start

First participant enrolled

May 1, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
7.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

2.6 years

First QC Date

April 24, 2013

Last Update Submit

July 2, 2024

Conditions

Keywords

inguinal hernia

Outcome Measures

Primary Outcomes (1)

  • Postoperative analgesic requirement after 1 week.

    Evaluation through Questionnaires, VAS, euraHS QOL, diary.

    1 week after the surgery.

Secondary Outcomes (1)

  • chronic pain at 3 months post-surgery.

    3 months post surgery.

Study Arms (2)

active kit

EXPERIMENTAL

Patient receives an active kit with pulsed electromagnetic field over wound surface area.

Device: Magnetic field therapy device

non-active kit

PLACEBO COMPARATOR

Patient receives a non-active kit.

Device: Non magnetic field therapy device.

Interventions

Therapy device for 1 week.

Also known as: Post-surgical and wound care recovery kit.
active kit

Non-active device for 1 week.

Also known as: Post-surgical and Wound care recovery kit.
non-active kit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent from the patient
  • Primary, unilateral and bilateral groin hernias

You may not qualify if:

  • No written informed consent
  • Recurrent hernias
  • 'Incarcerated' hernias
  • pregnant women: reaction of a Pulsed Electromagnetic Field on the foetus is unknown
  • Patients with pacemaker or Internal defibrillator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University Hospital

Ghent, 9000, Belgium

Location

Related Links

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Frederik Berrevoet, MD, PhD, FACS

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2013

First Posted

April 29, 2013

Study Start

May 1, 2013

Primary Completion

December 1, 2015

Study Completion

August 1, 2023

Last Updated

July 3, 2024

Record last verified: 2024-07

Locations